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Abstract: Plant extracts rich in phenolic compounds have been demonstrated to accelerate wound
healing, but their use by oral route has been poorly studied. The leaves of Vitis labrusca are rich in
phenolic acids and flavonoids. The goal of this study was to assess the healing properties of the
oral administration of hydroalcoholic extract of V. labrusca leaves (HEVL) in a murine model. HEVL
was obtained by Soxhlet and dynamic maceration, and their yield and phenolic acids and flavonoid
contents were determined. For the wound healing assay, 8 mm wounds were performed on the back
of 48 Wistar rats, assigned into four groups (n = 12): CTR (distilled water), HEVL100, HEVL200, and
HEVL300 (HEVL at 100, 200, and 300 mg/kg, respectively). On days 7 and 14, wound closure rates
were assessed, and the healing wounds were subjected to histological analysis. Soxhlet-obtained
extract was selected for the wound healing assay because it provided a higher yield and phenolic acid
and flavonoid contents. HEVL significantly reduced leukocytosis in the peripheral blood (p < 0.05),
accelerated wound closure (p < 0.05), and improved collagenization (p < 0.05) on day 7, as well as
enhanced the epidermal tissue thickness (p < 0.001) and elastic fiber deposition on day 14 (p < 0.01).
Furthermore, HEVL promoted an increase in the histological grading of wound healing on both days
7 and 14 (p < 0.01). The doses of 200 and 300 mg/kg provided better results than 100 mg/Kg. Our
data provide histological evidence that the oral administration of HEVL improves wound healing in
rodents. Therefore, the extract can be a potential oral medicine for healing purposes.
Keywords: plant extracts; flavonoids; phenols; oral administration; wound healing; Wistar rats
1. Introduction
Wound healing is a complex physiological process that occurs to restore skin integrity
after injury. This process involves the spatial and temporal synchronization of a variety
of cell types with distinct roles in the phases of hemostasis, inflammation, growth, re-
epithelialization, and remodeling [1,2]. Chronic wounds are characterized by long-term
impaired healing process, in which proper anatomical and functional results are not
achieved within an appropriate period of time, usually more than three months [3,4]. Such
injuries have become more frequent due to the increased incidence of diseases that hinder
wound healing, such as diabetes, obesity, and vascular diseases [5].
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The traditional treatment of chronic wounds is based on topical wound protection
procedures in order to provide a favorable environment for the development of patho-
physiological phenomena related to wound healing [6]. However, several factors must
be considered to choose the best route of drug administration in chronic wounds: (i) dys-
functional wound vasculature may reduce the bioavailability of drugs topically delivered;
(ii) the wound environment is rich in several pro-inflammatory cytokines that can disable
drugs; (iii) wound healing processes may be long-lasting, so drugs must be delivered
throughout the healing period [7]. Therefore, the long-term administration of drugs,
sometimes with distinctive modulatory activities, might be necessary to provide a proper
management of chronic wounds [8].
In recent years, plant extract-derived products have been demonstrated to improve
wound healing, either by reducing the influx in situ of inflammatory cells, stimulating
angiogenesis and fibroblastic proliferation, accelerating reepithelization, or even promot-
ing a combination of these pathophysiological effects [9,10]. Among the advantages of
these products, we highlight the presence of several active chemical compounds, easy
access and limited side effects. Different pharmacological targets are involved in the
healing effects of herbal products, depending on the phytochemical composition of the
extract, including negative modulation of inflammatory cytokines release, stimulation
of antioxidant enzymes to reduce oxidative stress, and modulation of angiogenesis [11].
Flavonoids are phytochemicals isolated from a wide variety of plants, represented by more
than 8000 chemical compounds, with well-recognized antioxidant and anti-inflammatory
effects [12–16]. These properties give flavonoid-rich plant extracts an important potential
for use in different formulations for wound healing applications [17].
Vitis labrusca is a species of grapevines belonging to the Vitis genus in the flowering
plant family Vitaceae, which is cultivated in more than 400 ha in a region called Agreste
in Northeastern from Brazil [18]. Hydroalcoholic extracts of leaves of V. labrusca (HEVL)
are rich in flavonoids, such as quercetin, kaempferol, and naringin [19,20]. Naringin
has demonstrated wound healing potential via ghd down-regulation of expression of
inflammatory (NF-κB, TNF-α, and ILs) and apoptotic factors (pol-γ and Bax), and up-
regulation of growth factor expression (VEGF and TGF-β), thus modulating collagen-1
expression to induce angiogenesis [21]. Quercetin has been proven to improve wound
healing by modulating αV and β1 integrin expression [22] and suppressing the MAPK
pathway [23]. In addition, kaempferol has been demonstrated to increase the levels of
hydroxyproline and maximum tensile strength, as well as accelerate reepithelization in
skin wounds of diabetic and non-diabetic rats [24]. Hence, the presence of such flavonoids
with wound healing properties in HEVL, as well as their modulatory effects on oxidative
stress and the inflammatory state that accompanies wound healing progression, strongly
suggests healing potential.
The ideal route of administration of any medication is the one that achieves serum
concentrations sufficient to produce the desired effect without inducing any serious adverse
side effects. In the oral administration, drugs are mostly absorbed in the small intestine to
reach the blood stream and are made available to the target tissues. This is an economical,
comfortable, painless route, and can promote both local and systemic effects [25]. The
efficiency of drug administration by oral route in experimental models of wound healing
in rodents has already been demonstrated in previous studies [2]. Therefore, the goal of
this study was to evaluate the potential use of hydroalcoholic extract of V. labrusca by the
oral route for wound healing in a murine model.
2. Materials and Methods
2.1. Plant Material
The leaves of Vitis labrusca were collected during November 2017 (from Areia Branca,
Sergipe, Brazil, 10◦45′29′′ S 37◦18′45′′ O) at the end of flowering and before fruiting. After
collection, the leaves were dried under shade, ground in a knife mill until a 32-mesh size
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was obtained, and stored in amber glass under controlled temperature (25 ± 2 ◦C) and
relative humidity (50 ± 5%).
2.2. Extraction Process
The extraction process was performed comparing two commonly used methods:
Soxhlet and dynamic maceration. In both extractive procedures, the proportion of solute
(dry sample, g): solvent (ethanol 70◦ g.L, 8 mL) used was 1:16 (w/v). The plant powder was
continuously extracted for 12 h at a maximum temperature of 45 ◦C (4 cycles, 60 min) in a
Soxhlet apparatus [26]. Dynamic maceration was carried out under constant mechanical
shaking (Fisatom 713 D mechanical stirrer, Unique Inc., London, UK, 500 rpm) at room
temperature for 24 h. The experiments were carried out in triplicate. Subsequently, the
solvent was removed. The dry extract was weighed and the yield was calculated and
expressed in mg of dry extract/g of raw material [27].
2.3. Assessment of Total Phenolic
The total phenolic content was assessed by Folin-Ciocalteu method using gallic acid
as standard. A 0.8 mL aliquot of the extract previously dissolved in methanol (1 mg/mL)
was added to a mixture of 9.2 mL of distilled water, 2 mL of Folin-Ciocalteu reagent (Sigma-
Aldrich, St. Louis, MO, USA) and 8 mL of 15% Na2CO3. The obtained solution was stirred
for 30 s. The absorbance of the samples was measured after 24 h. The calibration curve
was obtained using gallic acid standard solution and the absorbance determined at 750 nm
by UV–Vis spectrophotometer (Shimadzu UV 1650, Tokyo, Japan) (y = 0.0179x − 0.0394,
R = 0.996). The results were expressed as µg of gallic acid equivalent in relation to the
extract mass (µg GAE/g of extract) [28]. All analyses were carried out in triplicate.
2.4. Assessment of Total Flavonoids Content
The total flavonoid content was performed as previously described [29], using quercetin
as standard. The dry extract was dissolved in methanol (1 mg/mL) and an aliquot of 0.4 mL
of this solution was added to 0.5 mL of 2% AlCl3. After 30 min, the absorbance was mea-
sured at 420 nm at room temperature, against a blank sample without aluminum chloride.
The total of flavonoids was calculated using the equation from standard curve of quercetin
(y = 0.0087x + 0.0192, R = 0.991) and the results were expressed as µg of quercetin equivalent
in relation to the extract mass (µg QE/g extract). The yield of phenolic compounds and





where YGAE is the yield of GAE (µg GAE/g raw material), GAE is mass of phenolic acids






where YQE is the yield of QE (µg QE/g raw material), QE is mass of flavonoids equivalent
to quercetin (µg QE/g extract), and Y is extraction yield (g dry extract/100 g raw material).
2.5. Wound Healing Activity
The extract with the highest contents of phenolics and flavonoids was chosen for
wound healing activity assay. Ethical principles of the CONCEA (National Animal Experi-
ment Control Council) for experiments in animals were applied in this study, which was
approved by the Ethical Committee for Animal Experimentation (approval 020491). Forty-
eight male Wistar rats (300 ± 20 g) were anesthetized with intraperitoneal administration
of xylazine/ketamine (1:1, 5 mg/kg) and a rounded full-thickness wounds were performed
on the back of each animal (1 cm under the interscapular area) using an 8 mm biopsy punch.
The animals were randomly assigned into four groups (n = 18), as shown in Table 1. After
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7 and 14 days, six animals of each group were subjected to euthanasia in CO2 chamber (EB
248, 400× 320× 350 mm, Insight, São Paulo, Brazil) with a continuous flow of 100% carbon
dioxide for 5 min. After death certification, the wounded areas were surgically removed,
formalin-fixed, and paraffin-embedded according to routine histotechnical procedures.
Serial histological sections (5 µm thick) were obtained and further stained by histochemical
techniques [30].
Table 1. Distribution of the animals into the four experimental groups according to the treatment.
Groups (n = 12) Oral Treatment Dose (Volume)
CTR Distilled water –(1 mL)
HEVL 100 Hydroalcohic Extract of V. labrusca 100 mg/kg (1 mL)
HEVL 200 Hydroalcohic Extract of V. labrusca 200 mg/kg (1 mL)
HEVL 300 Hydroalcohic Extract of V. labrusca 300 mg/kg (1 mL)
2.6. Assessment of Wound Closure Rates (WCR)
Immediately after performing the experimental surgical procedures, as well as after
each euthanasia time, the animals were positioned on a plastic white platform and the
wounds were photographed using a digital camera (Olympus, C5060, São Paulo, Brazil), at
a standard distance of 30 cm from the horizontal base. The images were processed using
a morphometry software (Image J®, National Institute of Health, Bethesda, MD, USA)
to assess the wounded areas (at days 0, 7, and 14). Wound closure rates were obtained





where WCR is the wound closure rate, iWA is initial wounded area (day 0), and fWA is
final wounded area (day 7 and day 14). A clinical evaluation was also carried out and
a descriptive analysis of the macroscopic (gross) features of the wounds was performed
according the following criteria: edema, suppuration, and hyperemia [31].
2.7. Histological Analysis of Wound Healing
Twelve histological sections (5 µm thick) were obtained from each paraffin-embedded
surgical specimen and stained in hematoxylin-eosin (HE). A descriptive analytical study
of the inflammatory infiltrate, granulation tissue, primary fibrous scar (dense connective
tissue formed as a result of fibrosis of the granulation tissue), and epithelization process
was performed and a comparative analysis among groups was carried out. The histological
sections were examined by two examiners, who were blinded to the groups during all the
histological analysis performed in this study.
2.8. Assessment of the Mean Epidermal Thickness
Five histological fields (400 ×magnification, 0.04 mm2) of the epidermal tissue over
the scarred area were photomicrographed from each histological section. The top-down
epidermal thickness was measured in five different points (thickest points) using the
software Image J® (version 1.44, (National Institute of Health, Bethesda, MD, USA) to
obtain the mean thickness of the skin epithelial lining.
2.9. Assessment of Collagen and Elastic Fibers Content
The analysis of collagen fibers was carried out in three histological sections of each
animal stained in Sirius red and analyzed under polarized light. Collagen fibers were clas-
sified into type III or type I according to their birefringence pattern (green and yellow/red,
respectively). The morphological features (stretched/wavy, thin/thick, short/long) and
architectural arrangement (reticular, parallel, or interlaced) of the fibers were also observed.
Another three sections stained in Weigert were used to assess the content of elastic fibers
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under conventional light microscopy. In both studies, ten histological fields (400 ×magnifi-
cation, 0.025 mm2) of each histological section were photomicrographed and the percentage
of the area containing collagen/elastic was obtained using the software Image J®.
2.10. Assessment of Histological Grading of Wound Healing
From each paraffin-embedded sample 12 (twelve) histological sections were obtained,
arranged in glass slides (3 sections per slide, totaling a series of three slides per paraffin-
embedded sample). One slide from each series was stained in HE, Sirius red, Weigert and
toluidine blue, for analysis under conventional light (HE, Weigert and toluidine blue) and
polarized light (picrossirius) microscopy. The histological grading of the experimental
healing state was assessed in six serial sections of each animal (three of them stained in
HE, under conventional light microscopy, and three in Sirius red, under polarized light
microscopy). The analytical procedures were performed using a semi-quantitative scoring
system based on an ordinal scale considering six histological parameters related to the
healing process, as depicted in Table 2. The total healing score in each case was calculated
by adding the scores of individual criteria, with lower scores indicating poorer wound
healing. Healing status was graded as good (16–19), fair (12–15) and poor (8–11).






















Soxhlet 45 12 27.0 ± 2.4 a 270.1 ± 38.8 a 73.0 ± 13.4 a 78.4 ± 21.5 a 21.5 ± 7.6 a
Maceration 25 24 11.8 ± 2.3 b 232.6 ± 45.3 a 27.8 ± 8.8 b 63.3 ± 24.2 a 7.2 ± 1.8 b
p value 0.0014 0.3375 0.0081 0.4668 0.0336
Different letters in the same column mean significantly different values (T student test).
2.11. Statistical Analysis
Statistical analysis of the data was performed using the software PRISM 7.0. The data
were analyzed regarding their normality distribution using the Shapiro-Wilk test. Gaussian
data were analyzed by T student test (extraction data), analysis of variance (ANOVA)
and Tukey’s multiple comparisons test. Whereas non-Gaussian data were analyzed using
a Kruskal–Wallis test and Dunn’s multiple comparisons test. Chi-square test was used
to analyze possible associations between data with categorical distribution (contingency
analysis). The significance level adopted was 0.05.
3. Results and Discussion
3.1. Hydroalcoholic Extract of V. labrusca Obtained Using Soxhlet Extraction Process Provides
High Content of Phenolic Acids and Flavonoids
Table 2 shows the comparative the results of both extraction procedures consider-
ing the combination of yield and content of total phenolic and flavonoid. The Soxhlet
extraction (40 ◦C/12 h) provided extraction yield significantly higher than dynamic mac-
eration (p = 0.0014), and contents of total phenolic and flavonoid results presented values
statistically similar to the maceration ones (p = 0.3375 and p = 0.4668). However, the yield
values for GAE and QE were higher for the Soxhlet process, since the extract yield results
interfered positively in these values.
The conventional extraction methods, such as, dynamic maceration and Soxhlet
are able to extract considerable amounts of active substances with a relatively simple
apparatus. Dynamic maceration favors the better diffusion of the bioactive substances
through the solvent. In addition, the solvent shake minimizes the concentration of the
actives on the sample surface, providing an increase of the rate mass transport compared
to static methods, such as Soxhlet extraction. The yield of extraction was better in Soxhlet
process, even using a lower time of extraction. Despite both methodologies presenting
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similar amounts for active substances (phenolic acids and flavonoids), the yield was
higher for Soxhlet extraction. The room temperature and the saturation of solvent can be
considered limitations for dynamic maceration in this case. The temperature improved
the solubilization of the bioactive substances increasing the extraction rate. However, the
increase of temperature can degrade or volatilize some important substances. The use
of 45 ◦C for Soxhlet extraction avoided the degradation and volatilization of bioactive
substances. Soxhlet extraction is one of the most commonly used methods to obtain
bioactive compounds, including in comparison with advanced methods. The second
limitation of maceration is the solvent saturation. The renewable process of solvent in
Soxhlet process favors the extraction rate and avoid the solvent saturation using the same
volume. Thus, the Soxhlet-obtained extract of V. Labrusca was selected to be used in the
wound healing activity assay.
3.2. Hydroalcoholic Extract of V. labrusca Reduces Leukocytosis Counts in Peripheral Blood in
Early Stages of Wound Healing
Total leukocytes, neutrophils, lymphocytes and monocytes counts of the peripheral
blood in the experimental groups on days 7 and 14 are shown in Figure 1. Only a mild
increase in the total leukocytes count of the peripheral blood was observed in group CTR
(10.0 ± 0.3 × 103/mm3) over the reference values range on day 7. Oral administration of
HEVL not only significantly reduced total leukocyte counts (p < 0.001), but also brought
those mean counts into the reference range, regardless of the dose. As demonstrated in the
differential counts, although all the leukocytes’ counts were within the reference ranges,
neutrophils were significantly higher in CTR than in HEVL-treated groups (p < 0.05),
whereas no significant difference was observed in the lymphocytes and monocytes counts
between groups (p > 0.05). On day 14, all the leukocyte values were within the normal
reference range and no significant difference was observed between groups (p > 0.05).
Mild increase in the counts of total leukocytes on day 7 was already expected, as
the peak of the inflammatory phase of wound healing has already been gone at this
time. The relatively increased counts of neutrophils suggest that the mild leukocytosis
observed in CTR is likely because of a residual neutrophilia. Besides, the total leuko-
cytes count reduction induced by HEVL oral administration might be related with the
potential anti-inflammatory effects of the high contents of flavonoids present in the ex-
tract. Flavonoids can inhibit regulatory enzymes (e.g., cyclooxygenase, protein kinases
and phosphodiesterases), promoting decreased release of proinflammatory mediators such
as prostaglandins, decreased signal transduction, and decreased cell activation, as well
modulate transcription factors (e.g., NF-κB, GATA-3 and STAT-6), which leads to decreased
transcription of proinflammatory genes. Those biological activities might have shortened
the time-course of the acute phase of inflammation, accelerating the restoration of the
normal values of leukocytes counts. On the other hand, on day 14, the remodeling phase
of wound healing was already achieved, and no substantial inflammatory response was
supposed to be on course in any group [32], which can explain all the white blood cells
counts being within the normal reference range, as observed in the current study.
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Figure 1. As ess ent c nts on the peripheral blood of the animals of the xperimental groups on day 7
(A) and on day 14 (B). Red and blue pointed lines represent the u per and lower limits of the reference values. Data are
expressed as mean ± standard error mean. Significant differences in comparison with CTR are expressed as ** p < 0.01 and
*** p < 0.001(ANOVA and Tukey’s multiple comparison test).
3.3. Hydroalcoholic Extract of V. labrusca Accelerates Wound Close in Early Stages of
Wound Healing
No clinical or gross sign of intercurrences in wound healing, such as edema, erythema
or suppuration in the wound area, was observed over the time-course of the experimental
(Figure 2A). These data suggest absence of pathophysiological abnormalities that could
modify the natural course of wound healing and suggest that the experimental conditions
tested were proper for studying the course of the scar repair [18]. Since the 1980s, the pro-
gressive wound closure rates (WCR) represent one of the major clinical signs of scar repair
success. Thus, WCR is one of the most important parameters in studies of wound healing
in in vivo experimental models. On day 7, the mean values obtained in HEVL-treated
groups for doses of 100 (60.8 ± 3.1%), 200 (61.2 ± 3.2%) and 300 mg/Kg (62.7 ± 2.9%) were
significantly greater than in CTR group (47.1 ± 2.3%) (p < 0.05). However, no significant
difference was observed between the latter ones (p > 0.05). On day 14, no difference in the
wound closure percentages was observed between groups (p > 0.05) (Figure 2B).
The increase in WCR in the early stages of the repair process suggests that the oral
administration of HEVL accelerated the onset of wound closure, with no signs of adverse
clinical events, regardless of the dose tested. Supporting our findings, the healing activity
of several chemical compounds mainly present in the HEVL, such as kaempferol [24],
quercetin [33], luteolin [34], and curcumin [4], has been previously reported. However,
the precise pathophysiological mechanisms behind such biological effects remain unclear.
Acceleration of wound closure has been related with increased TGF-β (transforming
growth factor β)-induced differentiation of fibroblasts into myofibroblasts (cells with
contractile phenotype), promoting contraction and consequent reduction of the wound area.
However, flavonoids have been commonly reported to inhibit myofibroblast differentiation,
particularly those found as the major chemical compounds of HEVL, such as luteolin [35],
kaempferol [36] and quercetin [37]. Therefore, the increase of WCR in the early stages of
wound healing seems unlikely to be dependent on increased myofibroblast differentiation.
Furthermore, the lack of a significant difference in the WCR between groups at day 14
seems to support the theory that no myofibroblast over-differentiation occurred as a result
Curr. Issues Mol. Biol. 2021, 43 342
of HEVL oral administration. On the other hand, our previous data on the white blood cells
counts in the peripheral blood provided evidence that HEVL presented anti-inflammatory
effects. As downregulation of the inflammatory response by plant secondary metabolites
has been reported to successfully accelerate wound healing [38], it is possible to suppose
that the improved WCR obtained in HEVL-treated groups might have resulted in potential
inhibition of the onset and development of inflammatory phase of wound healing. Thus, a
reduction of the time-course of the acute inflammatory phase and downregulation of the
intensity of the further chronic inflammation would allow the earlier development of the
granulation tissues that cover and fill the wounded area and speed up wound closure.
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3.4. Hydroalcoholic Extract of V. labrusca Improves Histological Granulation Tissue and Primary
Fibrous Scar Formation
On day 7, all groups were characterized by granulation, with large strips of granulation
tissue involving the full thickness of the dermal tissue, and re-epithelization, which was
limited to the marginal areas of the wounds. In CTR group the granulation tissue showed
to be immature and rich in hyperemic slip-shaped capillary blood vessels, perpendicularly-
arranged in relation to the wound surface. The vascular content network is supported
by thin delicate collagen fibrils, in association with moderate spindle-shaped cells pro-
liferation (fibroblasts/myofibroblasts and endothelial cells). Although intense chronic
(lympho-histiocytic) inflammatory infiltrate was predominantly observed, persistence of
polymorphonuclear infiltrate was noted on the wound surface. Interstitial edema and hem-
orrhagic areas were common histological findings. The wounds of all the HEVL-treated
groups presented more cellular granulation tissue, characterized by spindle and ovoid
cells proliferating in long, parallel-arranged fascicles. Chronic inflammatory infiltrate was
persistent and ranged from moderate to intense, but the content of collagen fibers filling the
Curr. Issues Mol. Biol. 2021, 43 343
intercellular spaces was increased in comparison with CTR. However, edematous changes
and inflammation was less intense in HEVL 300 than in the other groups (Figure 3).
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Figure 3. Photomicrographs of histological sections stained in HE representative of the healing wound area in Wistar rats
of the experimental in day 7. (A–D) Panoramic view of CTR and treated with HEVL at doses of 100, 200 and 300 mg/Kg,
respectively. Note the non-epithelized wound surfaces (black arrows) (40×). (E) CTR shows immature vascular and
edematous granulation tissue, whereas (F) HEVL 100 and (G) 200 pres nts greater content of proliferative spindle-shape
cells (400×). (H) In HEVL 300, granulation tissue was less vascular and more cellular (400×).
The histological features of the healing wounds are consistent with the onset of
the proliferative phase of wound healing [39]. During the proliferative phase, growth
factors released essentially by macrophages stimulate the proliferation of fibroblasts and
endothelial cells (forming new blood vessels), which synthesize, secrete, and anchor in a
newly formed extracellular matrix known as granulation tissue.
Neovascularization is critical for efficient wound healing, since it is required for the
delivery of nutrients and maintenance of oxygen homeostasis, to allow cellular prolifera-
tion and tissue regeneration to occur. New blood vessels formation (angiogenesis) involves
activation of local microvascular endothelial cells (ECs), found lining the inner surface
of blood vessels. Growth factors, such as VEGF and PDGF, are released in response to
a hypoxic wound environment, activating ECs that break down ECM in the granulation
tissue, proliferate, migrate, form new cell-cell junctions, and branch out to form new capil-
laries [40]. Subsequently, fibroblasts promote the progressive deposition of extracellular
matrix to form fibrous connective tissue, which gradually replaces the network of newly
formed capillaries as it becomes denser and more compact. The gradual maturation of the
granulation tissue and subsequent transformation into the primary fibrous scar has been
considered one of the important morphological features of wound healing progression [41].
The regulation of the collagen synthesis is controlled by a wide range of growth factors,
such as TGF-β1 and FGF, which cause a strong effect upon the genic expression of this
protein. Hence, morphological features observed in HEVL-treated groups, consisting of
more cellular and fibrous tissue, suggest that the maturation of the granulation tissue is in
more advanced stages in comparison with CTR.
On day 14, all HEVL-treated groups presented full re-epithelialized wound surface
and, although the reepithelization was quite advanced in CTR, a short non-epithelized
area was seen in two cases. CTR exhibited persistence of mature (cellular and considerably
less vascular) granulation tissue and mild chronic inflammatory infiltrate, whereas a well-
Curr. Issues Mol. Biol. 2021, 43 344
collagenized primary fibrous scar presenting very scanty inflammatory cells and tiny and
sparsely distributed blood vessels was observed in HEVL-treated groups. In HEVL 200
and especially in 300, the lining epithelium was shown to be thickened and presented
several bulbous buds, sometimes with central keratinization, compatible with rudimentary
cutaneous appendages (hair follicles) (Figure 4).
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Figure 4. Photomicrographs of HE-stained histological sections representative of the healing wound area in Wistar rats
from different groups after 14 days of experiment. (A–D) Histological panoramic view highlighting the area of scar repair
in groups CTR and treated with HEVL at doses of 100, 200 and 300 mg/Kg, respectively. Note the presence of full re-
epithelialization of the wound surface (red arrows), as well as the diameter of the CTR healing area considerably larger than
in the HEVL-treated groups (thin d uble-headed arrows) (40×). Higher magnifications show thin keratinized squamous
epithelium with no morphological signs of cutaneous appendage differentia i n (E) CTR and (F) HEVL 100 (HE 400×).
(G) Group HEVL 200 and (H) HEVL 300 exhibiting bulbous buds, most of them with central keratinization, compatible
with hair follicles (400×). Black arrows in G and H point at the neoformation of cutaneous appendages (hair follicles). The
fibrous connective tissue (TCF) shows persistence of chronic inflammatory infiltrate in CTR whereas inflammation was
inconspicuous in the other groups.
The maturation of the healing tissue observed on day 14 occurs from the decrease in
the concentration of hyaluronic acid and the production of interstitial collagens, fibronectin,
elastin, and other matrix components by fibroblasts in response to the action of growth
factors. During this phase, fibroblasts undergo remarkable phenotypic and functional
transformations, initiating the progressive degradation of the high content of collagen,
replacing it with fibronectin and proteoglycans. This transformation in the components
of the extracellular matrix contributes to cell anchorage and migration, in addition to
preventing excessive fibrosis in the formation of the final fibrous scar. We also demonstrated
that HEVL oral administration accelerated morphological changes suggestive of improved
maturation of the granulation tissue.
Previous studies have demonstrated that, although cultured fibroblasts showed nor-
mal growth in response to treatment with quercetin, there was an increase in αV integrin
and a decrease in β-1 integrin expression on the cell surface. These changes in the expres-
sion of surface integrins appear to be contributing to the stimulation of fibroplasia-related
events, including the migration and production of extracellular matrix by fibroblasts. These
data could explain the faster fibroblastic maturation of the granulation tissue observed
in the groups treated with EHVL. On the other hand, the presence of kaempferol could
act as a modulator of this supposedly enhanced fibroblastic action, since this flavonoid
is able to inhibit collagen synthesis by fibroblasts in the scar by blocking the receptor for
type I TGF-β. As both quercetin and kaempferol have been reported to be major chemical
constituents of hydroalcoholic extracts of V. labrusca [19,20], the biological activities of these
Curr. Issues Mol. Biol. 2021, 43 345
flavonoids could explain the improvement in the granulation tissue maturation and faster
transformation into the primary fibrous scar, as well as ultimately prevent the formation of
hypertrophic scars at the end of the repair period.
3.5. The Highest Doses of Hydroalcoholic Extract of V. labrusca Improves the Thickness of the
Squamous Cell Epithelium on Day 14
As shown in Figure 5, the epidermal tissue in HEVL treated groups at doses of
200 (39.6 ± 2.6 µm) and 300 mg/kg (46.4 ± 1.7 µm) was significantly thicker than CTR
(27.9 ± 1.6 µm) and the group treated with HEVL at 100 mg/kg (29.9 ± 1.8 µm) (p < 0.001).
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Figure 5. (A) Photomicrographs of histological sections stained in HE representative of the scarring tissue in the healing
wound area of the experimental in day 14. The scar area is lined by keratinized squamous epithelium with presence
of rudimentary hair follicles in HEVL 200 and well-developed hair follicles in HEVL 300 (100×). (B) Assessment of
the epithelial thickness in the experimental groups on day 14. Data are expressed as median, interquartile range and
maximum and minimum values. Significant differences in relation to the CTR (control) group are expressed as *** p <0.001;
significant differences in comparison with HEVL 100 are expressed as ### p < 0.001 (Kruskal-Wallis test and Dunn’s multiple
comparison test).
The improvement of the epidermal tissue in the groups treated with HEVL is pos-
sibly related to the presence of quercetin in the extract. Quercetin has been previously
found to enhance proliferation of human oral keratinocytes via an upregulation of adhesion
molecules (Integrin-α6β4) and improved re-epithelization in vitro [42]. Proper keratinocyte
proliferation and migration is critical for achieving successful re-epithelialization, which
is an essential component of wound healing used as a defining parameter of a success-
ful wound closure. In addition to working as a protective clinical barrier between the
environment and the organism, epidermal keratinocytes interact with fibroblasts during
wound healing and modulate the expression of matrix metalloproteinases-2 and -9 and
their inhibitors, helping to prevent fibrosis. Ultimately, the thicker epithelial line associ-
ated with the presence of cutaneous appendages in different developing stages observed
in HEVL-treated groups at 200 and 300 might reflect a more mature condition of the
epidermal tissue.
3.6. Hydroalcoholic Extract of V. labrusca Improves Type III Collagen Deposition in Day 7 of
Wound Healing but Do Not Induce Excessive Type I Collagen Production in Day 14
In this study, a histochemical analysis of the collagen deposition, based on the bire-
fringence pattern of the fibers, using polarized light microscopy methods was performed
to assess the effects of HEVL oral administration on the collagenization over the time-
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course of wound healing (Figure 6). On day 7, all the groups showed mild deposition of
thin and predominantly short collagen fibrils was observed, with reticular arrangement,
interspersed by large interfibrillary spaces. Collagen fibrils exhibit a predominantly yellow-
green birefringence pattern, consistent with type III collagen. There was no difference in
the pattern of collagen deposition between CTR and HEVL 100, but HEVL 200 and 300
showed denser, more regular fibrillary deposition than the other groups. Furthermore,
collagen fibrils and fibers assumed reticular disposition in the center and top of the wounds,
whereas a parallel-arrangement was evident in the bottom. However, quantitative analysis
of the content of collagen fibers revealed that only HEVL 200 (19.1 ± 1.1%; p < 0.05) and
300 (22.4 ± 0.8%; p < 0.01) presented significantly more intense collagenization than CTR
(16.6 ± 0.9%), but no significant difference was observed when CTR was compared with
HEVL 100 (20.3 ± 1.2%) (p > 0.05). On day 14, a remarkable increase in collagenization,
as well as reduction of the interfibrillary spaces, could be observed in all groups. CTR,
however, presented the persistence of a substantial content of thin delicate type III collagen
(with green birefringence pattern) with variable arrangement, sometimes reticular or paral-
lel. Those fibrils were interspaced with type I collagen fibers, which were more easily found
in the bottom of the wounds. HEVL-treated groups showed very similar collagenization
pattern, characterized by predominance of thicker and longer type I collagen fibers, homo-
geneously deposited along the healing area. In addition, type I collagen fibers observed
in HEVL-300 appeared to be thicker and present a noticeable parallel-arrangement in
relation to the wound surface than in HEVL 100 and 200. However, quantitative analysis of
collagenization showed no significant difference in the percentage of collagen fiber contents
between CTR (58.7 ± 3.3%), HEVL 100 (65.2 ± 3.9%), HEVL 200 (64.3 ± 3.5%), and HEVL
300 (70.6 ± 3.6%) (p > 0.05).
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ent on the production of type III collagen. In days 5–7 of wound healing, fibroblasts mi-
grate into the wound, laying down new collagen of the subtypes I and III. Early in normal 
wound recovery, type III collagen predominates [43], supporting our morphological find-
ings on day 7. Type III collagen is first synthesized to provide a collagenous scaffold for 
endothelial cells migration to form the network of capillaries typically seen in the granu-
lation tissue in the early stages of wound healing. In this study, morphological analysis of 
Sirius-red stained histological sections showed a denser network of type III collagen in 
HEVL-treated animals at doses of 200 and 300 mg/kg, which was confirmed by histomor-
phometric analysis. In addition to provide a denser and more regular scaffold for attach-
ment and migration of endothelial cells and developing capillary blood vessels, support-
ing our previous findings of more rapid formation and maturation of granulation tissue 
in HEVL-treated groups, higher amounts of type III collagen molecules might have been 
contributory for wound closure improvement. In fact, impaired wound closure has been 
previously reported in type III collagen-deficient mice in comparison with controls [44]. 
This theory seems to support the best rates of wound closure observed in HEVL-treated 
groups on day 7. 
Over the time-course of wound healing the matrix deposited in the wounded area 
undergoes important changes in its composition. With the closure of the wound, type III 
collagen is gradually degraded, whereas synthesis of type I collagen increases [45], just as 
observed in the current study. Type I collagen accumulation speeds up reaching a peak at 
around day 10–14 when it accounts for at least 75% of total collagen in the granulation 
tissue [41]. The regulation of the collagen synthesis is controlled by a wide range of growth 
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** p <0.01 (ANOVA and Tukey’s multiple comparison test).
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Granulation tissue formation during early stages of wound healing is highly depen-
dent on the production of type III collagen. In days 5–7 of wound healing, fibroblasts
migrate into the wound, laying down new collagen of the subtypes I and III. Early in
normal wound recovery, type III collagen predominates [43], supporting our morpho-
logical findings on day 7. Type III collagen is first synthesized to provide a collagenous
scaffold for endothelial cells migration to form the network of capillaries typically seen in
the granulation tissue in the early stages of wound healing. In this study, morphological
analysis of Sirius-red stained histological sections showed a denser network of type III
collagen in HEVL-treated animals at doses of 200 and 300 mg/kg, which was confirmed by
histomorphometric analysis. In addition to provide a denser and more regular scaffold for
attachment and migration of endothelial cells and developing capillary blood vessels, sup-
porting our previous findings of more rapid formation and maturation of granulation tissue
in HEVL-treated groups, higher amounts of type III collagen molecules might have been
contributory for wound closure improvement. In fact, impaired wound closure has been
previously reported in type III collagen-deficient mice in comparison with controls [44].
This theory seems to support the best rates of wound closure observed in HEVL-treated
groups on day 7.
Over the time-course of wound healing the matrix deposited in the wounded area
undergoes important changes in its composition. With the closure of the wound, type III
collagen is gradually degraded, whereas synthesis of type I collagen increases [45], just as
observed in the current study. Type I collagen accumulation speeds up reaching a peak
at around day 10–14 when it accounts for at least 75% of total collagen in the granulation
tissue [41]. The regulation of the collagen synthesis is controlled by a wide range of growth
factors, such as TGF-β1 and FGF, which cause a strong effect upon the genic expression of
this protein [46]. Throughout the further remodeling phase, type I collagen molecules un-
dergo enhanced intermolecular crosslinking, which enhances the wound breaking strength,
although the original strength of the normal dermis is never fully restored. The persistence
of substantial amounts of reticular-arranged type III collagen fibers in CTR in contrast
with the clear predominance of parallel-arranged type I collagen fibers in the other groups
seems to suggest an improvement of collagen replacement in response to HEVL oral ad-
ministration. However, no significant difference in the collagenization was observed in
the histomorphometric analysis of collagen fiber deposits. Hence, we hypothesized that
despite the treatment with flavonoid-rich extract accelerated the replacement of type III for
type I molecules, it also modulated the collagenization process, avoiding excessive produc-
tion of collagen fibers. In fact, quercetin has previously proved to suppress the signaling
pathways activating RAW264.7 macrophages and dermal fibroblasts, which is associated
with inhibition of multiple tyrosine kinases and simultaneously downregulate the inflam-
matory and fibrotic responses in injured tissues. Quercetin also increases both mRNA and
protein levels of TGF-β3, an anti-fibrotic cytokine, without affecting pro-fibrotic TGF-β1
production [42]. In addition, Kaempferol treatment has demonstrated to significantly
reduce mRNA expression levels of inflammatory and pro-fibrotic cytokines, including IL-6,
TNF-α, and TGF-β in the lesioned skin. Furthermore, the reduction of the type III Collagen
network during granulation tissue formation upregulates myofibroblast differentiation
and potentially enhances scar deposition [44]. Thus, the increased deposition of these
molecules on day 7, as observed in HEVL-treated groups, might have reduced the risk of
further excessive deposition of type I collagen during wound healing, as observed in this
study.
3.7. The Highest Doses of Hydroalcoholic Extract of V. labrusca Improves Elastic Fibers Deposition
on Day 14
As demonstrated in Figure 7, elastic fibers were identified as very short thin and
delicate dark-stained fibrillary structures, which were disposed in parallel or reticular
arrangement, which were associated with grosser and thicker fibers collagen fibers. On day
7, elastic fibers were very scarce within the granulation tissue, and no remarkable difference
was observed between groups. This was confirmed by histomorphometric analysis, which
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showed no significant difference in the elastic fibers content of the experimental groups
(p > 0.05) On the 14 they were more noticeable, irregularly distributed and interlaced with
longer and thicker collagen fibers. In addition, the relative content of elastic fibrils seemed
to be more noticeable in HEVL-tread groups at doses of 200 and 300 ng/kg, and this finding
was confirmed by the histomorphometric analysis (p < 0.01 and p < 0.01, respectively).




Figure 7. (A) Photomicrographs representative of the pattern of elastic fibers distribution in the experimental groups. 
Elastic fibers are identified as short thin delicate dark-stained fibrillary structures that are scarcely seen on day 7 but more 
noticeable and irregularly organized on day 14 (Weigert stain, 1000×). (B) Assessment of elastic fibers deposition (percent-
age of collagen fibers content/0.025 mm2) within the healing areas in the experimental groups on days 7 day 14. Data are 
expressed as mean ± standard error of the mean. Significant differences in comparison with CTR are expressed as * p < 
0.05 and **p < 0.01 (ANOVA and Tukey’s multiple comparisons test). 
The elastic fibers are composed of relatively free and unstructured polypeptide 
chains covalently crossed to form an elastic net that allows the tissues to extend without 
damage. The interlacement of this fibrillary elastic network with collagen fibers limits the 
expansion and avoids the laceration of the dermal tissue, playing a key role in the for-
mation and improvement of final appearance of the scar at late stages of wound healing 
[47]. Furthermore, we provide histological evidence of a beneficial effect HEVL admin-
istration on the elastic fibers production during wound healing. As the direct effect of 
flavonoids, as isolated molecules or as chemical compounds of plant extracts has not been 
reported so far, the precise mechanisms underlying this biological activity is unclear. The 
oxidative stress has been proved to induce enhanced cross-linking of the tropoelastin mol-
ecules with other proteins required for elastic fiber assembly, including fibulin-4, fibulin-
5, and fibrillin-2, making them unable to properly form elastic fibers in an in vitro model 
(AKHTAR et al., 2010). Therefore, a possible role of the antioxidant activity of the flavo-
noids present in the HEVL on earlier stages of wound healing might be indirectly associ-
ated with the improvement of elastic fibers content on day 14. However, further investi-
gations must be performed to prove this theory right. 
3.8. Hydroalcoholic Extract of V. labrusca Improves Histological Grading of Wound Healing over 
the Time Course of the Experimental 
As in dermal wound healing assays performed in rodent model pathological features 
of the granulation tissue and primary fibrous scar have been more frequently assessed on 
day 7 and 14 days, respectively [27,48], those experimental times were chosen to assess 
the histological grading of wound healing. A variety of grading systems based on the his-
tological analysis of the healing process, including angiogenesis, inflammation, fibropla-
sia and restoration of the connective tissue matrix, wound contraction and remodeling, 
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m king them unable to properly form elastic fibers in an in vitro model (AKHTAR et al.,
2010). Therefore, a possible r l of the antioxidant activity of the flavonoids pr sent in
the HEVL on earlier stages of wound h aling might be directly associated with the
improvement of elastic fibers content on day 14. However, further investigations must be
performed to prove this the ry right.
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3.8. Hydroalcoholic Extract of V. labrusca Improves Histological Grading of Wound Healing over
the Time Course of the Experimental
As in dermal wound healing assays performed in rodent model pathological features
of the granulation tissue and primary fibrous scar have been more frequently assessed on
day 7 and 14 days, respectively [27,48], those experimental times were chosen to assess the
histological grading of wound healing. A variety of grading systems based on the histo-
logical analysis of the healing process, including angiogenesis, inflammation, fibroplasia
and restoration of the connective tissue matrix, wound contraction and remodeling, epithe-
lialization, and differentiation, has been proposed to assess the morphological features of
wound healing progression [47]. In the current study, the scoring system of six histological
parameters described by Sultana et al. (2009) [49], that included the most relevant morpho-
logical features that characterize granulation tissue and scar formation/maturation (Table
3), was selected and applied to assess wound healing progression.
Table 3. Histological parameters assessed to calculate f wound healing state.
Histological Parameter Scoring System Microscopy (Histochemical Technique)
Amount of granulation tissue profound-1, moderate-2, scanty-3, absent-4 Conventional light microscopy(HE stained)
Inflammatory infiltrate plenty-1, moderate-2, a few-4 Conventional light microscopy(HE stained)
Collagen fiber orientation vertical-1, mixed-2, horizontal-4 Polarized light microscopy(Sirius red stained)
Pattern of collagen reticular-1, mixed-2, fascicle-4 Polarized light microscopy(Sirius red stained)
Amount of early collagen profound-1, moderate-2, minimal-3, absent-4 Polarized light microscopy(Sirius red stained)
Amount of mature collagen profound-1, moderate-2, minimal-4 Polarized light microscopy(Sirius red stained)
On day 7, the scores of histological grading of wound healing, obtained in the CTR
group (9; 8–10) were significantly lower than in the HEVL-treated groups 100 (11; 9–12), 200
(12; 10–13) and 300 (11; 10–13) (p < 0.001), but no significant difference was observed when
the three doses tested were compared with each other ( p> 0.05). The profile obtained in
day 14 was a little different, as CTR (12; 12–14) and HEVL 100 (13; 12–15) were significantly
lower than in HEVL-200 (15; 14–16) and HEVL-300 (18; 16–19) (p < 0.001), but no significant
difference was observed when the last two groups were compared with each other ( p> 0.05)
(Figure 8). In addition, morphometric assessment of the epidermal tissue demonstrated
that the squamous epithelium in HEVL 200 (39.63 ± 2.6 µm) and 300 (46.92 ± 1.7 µm) was
significantly thicker than in CTR (27.99 ± 1.6 µm) and HEVL 100 (29.9 ± 1.8 µm) (p < 0.001)
(Figure 8).
Histological assessment should include the basic components of the healing process,
e.g., angiogenesis, inflammation, fibroplasia and connective tissue matrix restoration,
wound contraction and remodeling, epithelialization, and differentiation [50]. The amount
of granulation tissue, inflammatory infiltrate, orientation of collagen fibers/fibrils, collagen
deposition pattern, immature fibrillar collagen content, and fibrous mature collagen content
have been considered the main parameters to analyze the progress of wound healing in
experimental models. The comparison of histological patterns with known physiological
variations in tissue morphology helps in the qualitative derivation of the diagnosis. The
histological improvement of wound healing based on the scoring grading proposed by
Sultana et al. (2009) [49] was likely a result of the sum of different beneficial effects
induced by the extract that occurred at both early and late stages of the experiment.
Interestingly, although wound closure rates were not significantly different between groups,
the histological scores were greater in HEVL-treated animals, mainly at higher doses
(200 and 300 mg/kg). These data suggest that there is a relevant impact of the oral
Curr. Issues Mol. Biol. 2021, 43 350
administration of HEVL on the morphological features of the healing process and justifies
the use of the extract by oral route.
Curr. Issues Mol. Biol. 2021, 1, FOR PEER REVIEW 16 of 20 
 
 
epithelialization, and differentiation, has been proposed to assess the morphological fea-
tures of wound healing progression [47]. In the current study, the scoring system of six 
histological parameters described by Sultana et al. (2009) [49], that included the most rel-
evant morphological features that characterize granulation tissue and scar formation/mat-
uration (Table 3), was selected and applied to assess wound healing progression. 
Table 3. Histological parameters assessed to calculate f wound healing state. 
Histological Parameter Scoring System Microscopy (Histochemical Technique) 
Amount of granulation tissue 
profound-1, moderate-2, scanty-3, 
absent-4 
Conventional light microscopy  
(HE stained) 
Inflammatory infiltrate plenty-1, moderate-2, a few-4 
Conventional light microscopy 
(HE stained) 
Collagen fiber orientation vertical-1, mixed-2, horizontal-4 Polarized light microscopy  
(Sirius red stained) 
Pattern of collagen reticular-1, mixed-2, fascicle-4 
Polarized light microscopy  
(Sirius red stained) 
Amount of early collagen 
profound-1, moderate-2, minimal-3, 
absent-4 
Polarized light microscopy  
(Sirius red stained) 
Amount of mature collagen profound-1, moderate-2, minimal-4 Polarized light microscopy  
(Sirius red stained) 
On day 7, the scores of histological grading of wound healing, obtained in the CTR 
group (9; 8–10) were significantly lower than in the HEVL-treated groups 100 (11; 9–12), 
200 (12; 10–13) and 300 (11; 10–13) (p < 0.001), but no significant difference was observed 
when the three doses tested were compared with each other ( p> 0.05). The profile obtained 
in day 14 was a little different, as CTR (12; 12–14) and HEVL 100 (13; 12–15) were signifi-
cantly lower than in HEVL-200 (15; 14–16) and HEVL-300 (18; 16–19) (p < 0.001), but no 
significant difference was observed when the last two groups were compared with each 
other ( p> 0.05) (Figure 8). In addition, morphometric assessment of the epidermal tissue 
demonstrated that the squamous epithelium in HEVL 200 (39.63 ± 2.6 μm) and 300 (46.92 
± 1.7 μm) was significantly thicker than in CTR (27.99 ± 1.6 μm) and HEVL 100 (29.9 ± 1.8 
μm) (p < 0.001) (Figure 8). 
 
Figure 8. Assessment of wound healing histological grading scores in the experimental groups on day 7 (A) and 14 (B). 
Data are expressed as median, interquartile range and maximum and minimum values. Significant differences in relation 
to the CTR (control) group are expressed as *** p <0.001; and significant differences in comparison with HEVL 100 are 
expressed as ### p < 0.001 (Kruskal-Wallis test and Dunn’s multiple comparison test). 
 

































































Figure 8. Assessment of wound healing histological grading scores in the experimental groups on day 7 (A) and 14 (B). Data
are expressed as me ian, interquartile range and maximum and inimu values. Significant differences in relatio to the
CTR (control) group are express d as *** p <0.001; and significant differences in comparison with HEVL 100 are expressed
as ### p < 0.001 (Kruskal-Wallis test and Dunn’s multiple co parison test).
4. Conclusions
In this study, we analyzed the effect of hydroalcoholic extract of V. labrusca on wound
healing in a rodent model. Taken together, the results obtained in the current study
provide evidence that the administration of the extract by oral route can successfully
accelerate a variety of early and late pathophysiological steps that lead to improved wound
healing. Based on pathological examinations, hydroalcoholic extract of V. labrusca improved
wound closure, morphological features of the granulation tissue maturation, and type
III collagen formation at early stages of wound healing (day 7). In addition, the extract
also improved epidermal thickness, morphological features of the primary fibrous scar,
and elastic fiber deposition at late stages (day 14). Thus, the biological effects would be
ultimately responsible for improving the histological grading scores of wound healing.
Further investigations should be designed in order to evaluate the precise mechanisms
underlying healing properties related to the oral administration of hydroalcoholic extract
of V. labrusca in a rodent model of wound healing.
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